Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Concord Medical Services Holdings (CCM) EBITDA Margin (2016 - 2017)

Historic EBITDA Margin for Concord Medical Services Holdings (CCM) over the last 9 years, with Q2 2017 value amounting to 49.16%.

  • Concord Medical Services Holdings' EBITDA Margin fell 58300.0% to 49.16% in Q2 2017 from the same period last year, while for Jun 2017 it was 76.01%, marking a year-over-year decrease of 308800.0%. This contributed to the annual value of 67.35% for FY2016, which is 499600.0% down from last year.
  • Per Concord Medical Services Holdings' latest filing, its EBITDA Margin stood at 49.16% for Q2 2017, which was down 58300.0% from 43.32% recorded in Q2 2016.
  • Over the past 5 years, Concord Medical Services Holdings' EBITDA Margin peaked at 33.44% during Q4 2013, and registered a low of 126.56% during Q4 2015.
  • Moreover, its 5-year median value for EBITDA Margin was 12.06% (2013), whereas its average is 3.84%.
  • Per our database at Business Quant, Concord Medical Services Holdings' EBITDA Margin surged by 210500bps in 2014 and then tumbled by -1403900bps in 2015.
  • Over the past 5 years, Concord Medical Services Holdings' EBITDA Margin (Quarter) stood at 33.44% in 2013, then crashed by -59bps to 13.83% in 2014, then plummeted by -1015bps to 126.56% in 2015, then skyrocketed by 66bps to 43.32% in 2016, then dropped by -13bps to 49.16% in 2017.
  • Its last three reported values are 49.16% in Q2 2017, 43.32% for Q2 2016, and 15.49% during Q1 2016.